Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
Crossref DOI link: https://doi.org/10.1186/1471-2490-14-36
Published Online: 2014-05-12
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Andersson, Gustav
Wennersten, Christoffer
Gaber, Alexander
Boman, Karolina
Nodin, Björn
Uhlén, Mathias
Segersten, Ulrika
Malmström, Per-Uno
Jirström, Karin
License valid from 2014-05-12
Article History
Received: 25 November 2013
Accepted: 9 May 2014
First Online: 12 May 2014